Inhibitors | Comment | Organism | Structure |
---|---|---|---|
bis-[(L-valine-N-methylamide)-2-phenyl-3-yl-propionamide] sulfide | - |
Human immunodeficiency virus 1 | |
bis-[(L-valine-N-methylamide)-2-phenyl-3-yl-propionamide] sulfoxide | - |
Human immunodeficiency virus 1 | |
bis-[(L-valine-N-methylamide)-2-phenyl-3-yl-propionamide] sulfoximine | - |
Human immunodeficiency virus 1 | |
bis-[[N-(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-2S-phenyl-3-yl-propionamide] sulfoximine | - |
Human immunodeficiency virus 1 | |
bis-[[N-(2R)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfide | - |
Human immunodeficiency virus 1 | |
bis-[[N-(2R)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfoxide | - |
Human immunodeficiency virus 1 | |
bis-[[N-(2R)-phenylglycinol]-2-phenyl-3-yl-propionamide]sulfoximine | - |
Human immunodeficiency virus 1 | |
bis-[[N-(2S)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfide | - |
Human immunodeficiency virus 1 | |
bis-[[N-(2S)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfoxide | - |
Human immunodeficiency virus 1 | |
bis-[[N-(2S)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfoximine | - |
Human immunodeficiency virus 1 | |
N-methyl bis-[N-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[(1S,2R)-1,2]-oxazol-3-yl) 2R-benzyl-3-yl propianamide] sulfoximine | - |
Human immunodeficiency virus 1 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human immunodeficiency virus 1 | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
HIV-1 protease | - |
Human immunodeficiency virus 1 |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
bis-[[N-(2S)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfide | 41% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[[N-(2S)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfoxide | 47% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[[N-(2R)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfoxide | 50% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[[N-(2R)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfide | 51% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[[N-(2R)-phenylglycinol]-2-phenyl-3-yl-propionamide]sulfoximine | 54% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[[N-(2S)-phenylglycinol]-2-phenyl-3-yl-propionamide] sulfoximine | 87% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[(L-valine-N-methylamide)-2-phenyl-3-yl-propionamide] sulfide | 87% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[(L-valine-N-methylamide)-2-phenyl-3-yl-propionamide] sulfoxide | 90% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
additional information | - |
bis-[(L-valine-N-methylamide)-2-phenyl-3-yl-propionamide] sulfoximine | 99% inhibition at 0.01 mM | Human immunodeficiency virus 1 | |
0.0000025 | - |
bis-[[N-(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-2S-phenyl-3-yl-propionamide] sulfoximine | - |
Human immunodeficiency virus 1 | |
0.00046 | - |
N-methyl bis-[N-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[(1S,2R)-1,2]-oxazol-3-yl) 2R-benzyl-3-yl propianamide] sulfoximine | - |
Human immunodeficiency virus 1 |